# Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease

> **NCT05152160** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shenzhen University General Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Graft Vs Host Disease

## Interventions

- **BIOLOGICAL:** Umbilical Cord Mesenchymal Stem Cell Therapy

## Key facts

- **NCT ID:** NCT05152160
- **Lead sponsor:** Shenzhen University General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-01
- **Primary completion:** 2024-08
- **Final completion:** 2024-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05152160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05152160, "Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05152160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*